WallStreetZenWallStreetZen

NASDAQ: ATHA
Athira Pharma Inc Stock Ownership - Who owns Athira Pharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Athira Pharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mark James LittonCEO2024-01-054,820$2.91
$14.03kSell
Rachel LeningtonChief Operating Officer2024-01-052,412$2.91
$7.02kSell
Andrew GengosCFO AND CHIEF BUSINESS OFFICER2024-01-051,208$2.91
$3.52kSell
Mark WorthingtonGENERAL COUNSEL2024-01-052,412$2.91
$7.02kSell
Kevin ChurchCHIEF SCIENTIFIC OFFICER2024-01-052,412$2.91
$7.02kSell
Mark WorthingtonGeneral Counsel2024-01-052,412$2.91
$7.02kSell
Rachel LeningtonCOO AND CDO2024-01-052,412$2.91
$7.02kSell
Mark James LittonChief Executive Officer2024-01-054,820$2.91
$14.03kSell
Perceptive Advisors LLCDirector2023-12-29163,954$2.38
$390.21kBuy
Perceptive Advisors LLCDirector2023-12-28409,598$2.44
$999.42kBuy

1 of 3

ATHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATHA insiders and whales buy or sell their stock.

ATHA Shareholders

What type of owners hold Athira Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC14.10%5,402,964$10.37MInsider
Perceptive Advisors LLC14.10%5,402,964$10.37MInstitution
Baker Bros Advisors LP8.23%3,153,807$6.06MInstitution
Joseph Edelman8.13%3,114,805$5.98MInsider
Rtw Investments LP6.96%2,668,913$5.12MInsider
Vanguard Group Inc4.43%1,698,453$3.26MInstitution
Propel Bio Management LLC3.89%1,492,792$2.87MInstitution
Simplify Asset Management Inc3.89%1,492,792$2.87MInstitution
Bml Capital Management LLC3.79%1,454,362$2.79MInstitution
Tang Capital Management LLC3.01%1,152,715$2.21MInstitution

1 of 3

ATHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATHA57.11%31.41%Net Buying
PASG43.60%56.40%Net BuyingNet Selling
CNTB12.92%0.00%
YS10.08%0.00%
CVM12.96%43.81%Net BuyingNet Buying
View Top Biotech Stocks

Athira Pharma Stock Ownership FAQ

Who owns Athira Pharma?

Athira Pharma (NASDAQ: ATHA) is owned by 57.11% institutional shareholders, 31.41% Athira Pharma insiders, and 11.48% retail investors. Perceptive Advisors LLC is the largest individual Athira Pharma shareholder, owning 5.40M shares representing 14.10% of the company. Perceptive Advisors LLC's Athira Pharma shares are currently valued at $10.37M.

If you're new to stock investing, here's how to buy Athira Pharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.